Day 1 · 21 April 2022
Regulation, market access and clinical practice
Opening keynotes, regulatory and reimbursement insight, clinical case studies and the first round of panel discussion.
Day 1 detailTwo working days of keynotes, clinical case studies, panel discussions, product demonstrations and exhibition time, built around six themes that define the Korean medtech market.
Programme overview
MKS 2022 combines high level keynotes, clinical case studies and interactive panel discussions from leading hospitals, universities, research institutes and medtech companies. Product demos from innovative medtech startups run alongside the conference, with an exhibition area for the latest products, solutions and technological advancements.
The programme moves from regulation and market access on the opening day through to innovation, investment and commercial growth on the second day. Each day reserves time for structured networking so delegates can build partnerships across the Korean medtech ecosystem.
Day 1 · 21 April 2022
Opening keynotes, regulatory and reimbursement insight, clinical case studies and the first round of panel discussion.
Day 1 detailDay 2 · 22 April 2022
R and D, digital healthcare, startup showcases, investor perspectives and commercial and distribution strategy.
Day 2 detailForum formats
High level sessions setting out the direction of the Korean medical device industry.
Practical insight from leading hospitals and clinicians working with advanced devices.
Interactive debate between hospitals, universities, research institutes and industry.
Live demonstrations from innovative medtech startups and established makers.
An exhibition area showing the latest products, solutions and technology.
Dedicated time to build partnerships across the medtech ecosystem.
Themes
Theme 01
Theme 02
Theme 03
Theme 04
Theme 05
Theme 06
Context
Korea is ranked 4th among healthcare markets in Asia Pacific and imports 63% of domestically used devices, making it a prime destination for medical device manufacturers.
The agenda is shaped by the market reality that Korean medical device makers exported 5.7 billion US dollars in 2020, a 44% increase, and by the government's Vision 2030 plan to strengthen the sector.
Related organizations